Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases

…, P Pillet, E Haddad, P Hubert, AM Prieur - The Journal of …, 1996 - Elsevier
OBJECTIVES: To evaluate the efficacy of cyclosporine A in the treatment of macrophage
activation syndrome (MAS) occurring in children with juvenile arthritis. STUDY DESIGN …

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

…, W Kuis, C Machado, L Pachman, AM Prieur… - …, 2003 - academic.oup.com
Objective. To identify preliminary core sets of outcome variables for disease activity and
damage assessment in juvenile systemic lupus erythematosus (JSLE) and juvenile …

Cryopyrinopathies: update on pathogenesis and treatment

B Neven, AM Prieur, PQ dit Maire - Nature clinical practice …, 2008 - nature.com
Cryopyrinopathies are a group of rare autoinflammatory diseases that includes familial cold
autoinflammatory syndrome, Muckle–Wells syndrome and chronic infantile neurologic …

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

…, J Orozco-Alcala, AM Prieur… - The Journal of …, 2004 - pubmed.ncbi.nlm.nih.gov
International League of Associations for Rheumatology classification of juvenile idiopathic
arthritis: second revision, Edmonton, 2001 International League of Associations for …

Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997

…, J Orozco-Alcala, AM Prieur - Journal of …, 1998 - api.taylorfrancis.com
For many years a united international classification for chronic childhood arthritis has been
absent. The lack of consensus has led to difficulties in trial structure and data interpretation …

EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides

…, T Kawasaki, C Lindsley, RE Petty, AM Prieur… - Annals of the …, 2006 - ard.bmj.com
Background: There has been a lack of appropriate classification criteria for vasculitis in
children. Objective: To develop a widely accepted general classification for the vasculitides …

CARD15 mutations in Blau syndrome

C Miceli-Richard, S Lesage, M Rybojad, AM Prieur… - Nature …, 2001 - nature.com
We have identified three missense mutations in the nucleotide-binding domain (NBD) of
CARD15/NOD2 in four French and German families with Blau syndrome. Our findings …

[PDF][PDF] Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and …

J Feldmann, AM Prieur, P Quartier, P Berquin… - The American Journal of …, 2002 - cell.com
Chronic infantile neurological cutaneous and articular (CINCA) syndrome is a severe
chronic inflammatory disease of early onset, characterized by cutaneous symptoms, central …

A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

…, V Gerloni, P Lahdenne, AM Prieur… - … : Official Journal of …, 2007 - Wiley Online Library
Objective To evaluate the safety and efficacy of infliximab in the treatment of juvenile
rheumatoid arthritis (JRA). Methods This was an international, multicenter, randomized …

Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients

…, R Mouy, B Bader‐Meunier, AM Prieur - …, 2001 - academic.oup.com
Background. The reactive haemophagocytic syndrome (RHS) is a little‐known life‐
threatening complication of rheumatic diseases in children. It reflects the extreme …